I 
26.22
+3.03%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$52.56bn
FY2016FY2025
Net income
$327.9m
FY2016FY2025
Free cash flow
$785.4m
FY2016FY2025
Shareholders' equity
$4.25bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $52.56bn | $47.98bn | $48.04bn | $50.82bn | $54.46bn | $49.12bn | $47.20bn | $50.44bn | $46.67bn | $41.93bn |
| Gross profit | $3.50bn | $3.44bn | $3.55bn | $3.69bn | $4.11bn | $3.61bn | $3.35bn | $3.18bn | $2.95bn | $2.86bn |
| Operating income | $936.7m | $817.9m | $944.3m | $3.25bn | $849.3m | $890.3m | $697.8m | $550.6m | $408.7m | $277.7m |
| Net income | $327.9m | $264.2m | $352.7m | $2.39bn | $475.2m | $640.5m | $503.6m | $352.2m | $199.0m | $100.4m |
| Diluted earnings per share | 1.39 | 1.13 | 1.50 | 10.20 | 2.02 | 2.73 | 2.14 | 0.00 | 0.00 | 0.00 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $21.24bn | $18.78bn | $18.42bn | $19.09bn | $19.80bn | $17.73bn | $15.47bn | $15.46bn | $15.37bn | $13.72bn |
| Cash and short-term investments | $1.86bn | $918.4m | $948.5m | $1.32bn | $1.23bn | $1.41bn | $671.8m | $533.9m | $549.6m | $796.2m |
| Total liabilities | $17.00bn | $15.05bn | $14.91bn | $16.03bn | $17.10bn | $12.72bn | $10.80bn | $11.07bn | $11.05bn | $9.61bn |
| Debt | $3.30bn | $3.45bn | $4.03bn | $4.37bn | $4.92bn | $222.8m | $142.4m | $175.2m | $127.5m | $559.8m |
| Shareholders' equity | $4.25bn | $3.73bn | $3.51bn | $3.06bn | $2.69bn | $5.01bn | $4.67bn | $4.40bn | $4.32bn | $4.11bn |
| Shares outstanding | 235m | 235m | 235m | 235m | 235m | 235m | 235m | 1,271,127m | 1,271,127m | 1,271,127m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $916.1m | $333.8m | $58.8m | −$361.1m | −$1.16bn | $1.49bn | $561.7m | $904.8m | −$639.4m | −$62.1m |
| Capital spending | −$130.8m | −$142.7m | −$201.5m | −$135.8m | −$126.3m | −$135.1m | −$168.8m | −$136.9m | −$139.6m | −$110.6m |
| Free cash flow | $785.4m | $191.1m | −$142.7m | −$496.9m | −$1.29bn | $1.36bn | $392.9m | $767.9m | −$779.0m | −$172.7m |
| Dividends paid | −$78.4m | −$6.2m | −$10.5m | −$1.75bn | −$430.4m | −$359.9m | −$248.7m | −$182.5m | −$105.8m | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.53bn | $13.96bn | $14.88bn | $12.60bn | $12.79bn | $12.28bn | $13.34bn | $11.76bn |
| Gross profit | $958.7m | $926.0m | $966.4m | $869.6m | $839.2m | $828.8m | $936.1m | $845.5m |
| Operating income | $244.3m | $232.4m | $323.4m | $232.0m | $176.3m | $205.0m | $264.8m | $218.2m |
| Net income | $110.9m | $98.9m | $121.4m | $99.5m | $37.8m | $69.2m | $83.1m | $77.0m |
| Diluted earnings per share | 0.48 | 0.43 | 0.52 | 0.42 | 0.16 | 0.29 | 0.35 | 0.33 |
| Cash from operations | −$533.0m | −$977.0m | $1.56bn | −$146.0m | −$297.0m | −$200.0m | $309.0m | −$277.0m |
| Capital spending | −$32.0m | −$36.0m | −$36.0m | −$28.0m | −$35.0m | −$29.0m | −$36.0m | −$37.0m |
| Free cash flow | −$565.0m | −$1.01bn | $1.52bn | −$174.0m | −$332.0m | −$229.0m | $273.0m | −$314.0m |
| Total assets | $21.53bn | $20.95bn | $21.24bn | $19.22bn | $19.45bn | $18.63bn | $18.78bn | $18.56bn |
| Cash and short-term investments | $809.0m | $916.0m | $1.86bn | $802.6m | $856.7m | $881.6m | $918.4m | $849.5m |
| Debt | $3.90bn | $3.45bn | $3.30bn | $3.06bn | $3.04bn | $3.03bn | $3.17bn | $3.34bn |
| Shareholders' equity | $4.28bn | $4.20bn | $4.25bn | $4.10bn | $4.05bn | $3.86bn | $3.73bn | $3.61bn |
Financial ratios
Data as of 16 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2015 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 6.7% | 7.2% | 7.4% | 7.3% | 7.5% | 7.3% | — |
| Operating margin | 1.6% | 1.6% | 1.9% | 6.2% | 1.8% | 1.9% | — |
| Net margin | 0.6% | 0.6% | 0.7% | 4.7% | 0.9% | 1.3% | — |
| Return on equity | 7.7% | 7.1% | 10.1% | 78.3% | 17.6% | 12.8% | — |
| Return on assets | 1.5% | 1.4% | 1.9% | 12.5% | 2.4% | 3.6% | — |
| Free cash flow yield | 16.5% | 7.5% | 4.1% | -3.6% | -16.3% | 25.7% | — |
| Revenue growth | 9.5% | -0.1% | -5.5% | -6.7% | 10.9% | 4.1% | — |
| Earnings growth | 24.1% | -25.1% | -85.3% | 403.9% | -25.8% | 27.2% | — |
| Current ratio | 1.33x | 1.40x | 1.44x | 1.43x | 1.39x | 1.36x | — |
| Debt to equity | 0.78x | 0.92x | 1.15x | 1.46x | 1.83x | 0.04x | — |
| Equity ratio | 20.0% | 19.9% | 19.0% | 16.0% | 13.6% | 28.3% | — |
| Interest coverage | 2.75x | 2.32x | 2.37x | 9.79x | 3.10x | 10.66x | — |
| R&D as a share of sales | — | — | — | — | — | — | 0.3% |
| Buybacks as a share of market value | -0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 1.1% | 1.4% | 2.0% |
| Operating income | -33.9% | 1.0% | 8.5% |
| Net income | -48.5% | -12.5% | 4.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 6.9% | 7.1% | 7.2% | 6.9% |
| Operating margin | 1.7% | 3.0% | 2.5% | 1.9% |
| Net margin | 0.6% | 1.7% | 1.5% | 1.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | |
|---|---|---|
| Price to earnings | 15.3 | 17.2 |
| Price to sales | 0.1 | 0.1 |
Market value over time
31 Oct 2024 to 15 Oct 2026, in USD
$5.38bn$6.27bn
Share price return
Finished calendar years
| 2025 | 2024 | |
|---|---|---|
| Return | 12% | -20% |
Dividends and splits
Per share, in the currency the company pays
Paid for 1 years. Last went ex-dividend on 11 Aug 2026.
| FY2026 | FY2025 | |
|---|---|---|
| Paid in the year | 0.252 | 0.308 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.